With respect to insulin, TZP was associated with a lower risk of “diabetic retinopathy” (ROR 0.14, 95% CI 0.08–0.24) and a greater risk of “medullary thyroid cancer” (ROR 2.88, 95% CI 1.37–1.82). This evidence concerns the gene INS and diabetic retinopathy.